These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 27053539)

  • 1. Hypothyroid cardiomyopathy in a patient post-doxorubicin chemotherapy.
    Silver AJ; Patel HN; Okwuosa T
    BMJ Case Rep; 2016 Apr; 2016():. PubMed ID: 27053539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recovery from anthracycline cardiomyopathy--how can it be explained?
    Christiansen S
    J Heart Lung Transplant; 2009 Jul; 28(7):751. PubMed ID: 19560709
    [No Abstract]   [Full Text] [Related]  

  • 3. Primary Prevention Strategies for Anthracycline Cardiotoxicity: A Brief Overview.
    Menna P; Salvatorelli E
    Chemotherapy; 2017; 62(3):159-168. PubMed ID: 28122377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The feature of cardial remodeling process at Doxorubicin chemotherapy and idiopathic dilatative cardiomyopathy].
    Katamadze NA; Lartsuliani KP; Begishvili NN; Dundua KhV; Kiknadze MP
    Georgian Med News; 2006 Jan; (130):61-4. PubMed ID: 16510915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Appraising cardiotoxicity associated with liposomal doxorubicin by means of tissue Doppler echocardiography end-points: rationale and design of the LITE (Liposomal doxorubicin-Investigational chemotherapy-Tissue Doppler imaging Evaluation) randomized pilot study.
    Lotrionte M; Palazzoni G; Natali R; Comerci G; Abbate A; Di Persio S; Biondi-Zoccai GG
    Int J Cardiol; 2009 Jun; 135(1):72-7. PubMed ID: 18572266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acute cardiogenic postoperative edema after doxorubicin (adriamycin) chemotherapy].
    Boulay G; Debaene B
    Ann Fr Anesth Reanim; 1998; 17(1):43-6. PubMed ID: 9750682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left ventricular assist device as destination therapy in doxorubicin-induced cardiomyopathy.
    Simsir SA; Lin SS; Blue LJ; Gockerman JP; Russell SD; Milano CA
    Ann Thorac Surg; 2005 Aug; 80(2):717-9. PubMed ID: 16039240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left ventricular function in patients with toxic cardiomyopathy and with idiopathic dilated cardiomyopathy treated with Doxorubicin.
    Katamadze NA; Lartsuliani KP; Kiknadze MP
    Georgian Med News; 2009 Jan; (166):43-8. PubMed ID: 19202217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversible Cardiomyopathy After Epirubicin Administration.
    Koitabashi N; Ohyama Y; Tateno R; Arai M; Rokutanda N; Horiguchi J; Kurabayashi M
    Int Heart J; 2015; 56(4):466-8. PubMed ID: 26104177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hypothyroid cardiomyopathy--an underdiagnosed cause of heart failure].
    Gundersen T; Paulsen AQ; Gallefoss F; Aslaksen BB
    Tidsskr Nor Laegeforen; 1990 Jun; 110(15):1948-51. PubMed ID: 2141958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doxorubicin-induced cardiac dysfunction in unselected patients with a history of early-stage breast cancer.
    Caram MEV; Guo C; Leja M; Smerage J; Henry NL; Giacherio D; Rubenfire M; Schott A; Davis M; Hayes DF; Van Poznak C; Cooney KA; Hertz DL; Banerjee M; Griggs JJ
    Breast Cancer Res Treat; 2015 Jul; 152(1):163-172. PubMed ID: 26050157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subclinical late cardiomyopathy after doxorubicin therapy for lymphoma in adults.
    Hequet O; Le QH; Moullet I; Pauli E; Salles G; Espinouse D; Dumontet C; Thieblemont C; Arnaud P; Antal D; Bouafia F; Coiffier B
    J Clin Oncol; 2004 May; 22(10):1864-71. PubMed ID: 15143078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysing the risk factors of doxorubicin-associated heart failure by a retrospective study of integrated, nation-wide databases].
    Fogarassy G; Fogarassyné Vathy Á; Kováts T; Hornyák L; Kenessey I; Veress G; Polgár C; Forster T
    Orv Hetil; 2020 Jun; 161(26):1094-1102. PubMed ID: 32541088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doxorubicin-induced cardiomyopathy.
    Ginsburg AD
    N Engl J Med; 1999 Feb; 340(8):654; author reply 655. PubMed ID: 10049086
    [No Abstract]   [Full Text] [Related]  

  • 15. Peripartum cardiomyopathy occurring in a patient previously treated with doxorubicin.
    Katz A; Goldenberg I; Maoz C; Thaler M; Grossman E; Rosenthal T
    Am J Med Sci; 1997 Dec; 314(6):399-400. PubMed ID: 9413345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies.
    Octavia Y; Tocchetti CG; Gabrielson KL; Janssens S; Crijns HJ; Moens AL
    J Mol Cell Cardiol; 2012 Jun; 52(6):1213-25. PubMed ID: 22465037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HSP27 role in cardioprotection by modulating chemotherapeutic doxorubicin-induced cell death.
    Ramani S; Park S
    J Mol Med (Berl); 2021 Jun; 99(6):771-784. PubMed ID: 33728476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doxorubicin cardiomyopathy.
    Chatterjee K; Zhang J; Honbo N; Karliner JS
    Cardiology; 2010; 115(2):155-62. PubMed ID: 20016174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indium-111-antimyosin scintigraphy in the early detection of heart damage after anthracycline therapy in children.
    Kremer LC; Tiel-van Buul MM; Ubbink MC; Offringa M; Ottenkamp J; Olmos RV; Voûte PA
    J Clin Oncol; 1999 Apr; 17(4):1208. PubMed ID: 10561180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dilated cardiomyopathy in a pregnant woman after doxorubicin and radiotherapy for Hodgkin's disease: a case report.
    Hadar A; Sheiner E; Press F; Katz A; Katz M
    J Reprod Med; 2004 May; 49(5):401-3. PubMed ID: 15214719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.